SOURCE: Corporate Profile

Corporate Profile

June 16, 2010 12:45 ET

Corporate Profile's Publishes Goldman Small Cap Research's Recommendation on Rexahn

NEW YORK, NY--(Marketwire - June 16, 2010) -  Corporate Profile's financial website announces recommendation of Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN). 

In an update issued today, Goldman expects Rexahn's shares to move higher based upon recent events such as investment bank engagement and upcoming events, including the receipt of another milestone investment.

About features Gene Marcial's Inside Wall Street Newsletter, published three times a week exclusively on . The website and newsletter provide readers and subscribers fresh, original, and highly informative ideas and market commentary that they won't get anywhere else. Content is focused on what is going on in the stock market and on Wall Street, including stories about large-capitalization as well as small-cap companies, both on the long and short side.

About Corporate is a broadcasting website where Fashion meets Finance. Merging two mainstream industries results in the unique platform for today's hottest tips and market info.

About Goldman Small Cap Research
Led by former Piper Jaffray analyst and mutual fund manager Rob Goldman, Goldman Small Cap Research produces stock market research reports. The Firm produces research via two formats: Goldman Select Research and Goldman Opportunity Research. The Select product reflects the Firm's internally generated stock ideas while the Opportunity product reflects sponsored research reports. While performance is tracked separately, the same coverage criteria are utilized in determining coverage of all stocks in both. For more information, visit

Safe Harbor Disclaimer
Under The Private Securities Litigation Reform Act of 1995: Except for historical information contained herein, the statements in this news release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause a company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. These risks and uncertainties are described in the Company's periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectation.